Français
ItalianoBond Celgen Corporation 2.875% ( US151020AQ72 ) in USD
| Issuer | Celgen Corporation |
| Market price | 100 % ⇌ |
| Country |  United States
|
| ISIN code |
 US151020AQ72 ( in USD )
|
| Interest rate | 2.875% per year ( payment 2 times a year) |
| Maturity | 14/08/2020 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 500 000 000 USD |
| Cusip | 151020AQ7 |
| Standard & Poor's ( S&P ) rating | N/A |
| Moody's rating | N/A |
| Detailed description |
Celgene Corporation was a biopharmaceutical company acquired by Bristol Myers Squibb in 2019, known for its development and commercialization of cancer therapies and other immunology treatments. The Bond issued by Celgen Corporation ( United States ) , in USD, with the ISIN code US151020AQ72, pays a coupon of 2.875% per year. The coupons are paid 2 times per year and the Bond maturity is 14/08/2020 |